<?xml version="1.0"?> <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">   <id>9fe06ad4-4741-4f36-bb0c-36deafe261b7</id>   <name>Palliative Acute Care Admission Medication Order Panel</name>   <description>     <lifecycle_state>Initial</lifecycle_state>     <details>       <purpose/>       <use/>       <misuse/>     </details>     <other_details>       <item>         <key>MetaDataSet:Sample Set </key>         <value>Template metadata sample set </value>       </item>       <item>         <key>Acknowledgements</key>         <value/>       </item>       <item>         <key>Business Process Level</key>         <value/>       </item>       <item>         <key>Care setting</key>         <value/>       </item>       <item>         <key>Client group</key>         <value/>       </item>       <item>         <key>Clinical Record Element</key>         <value/>       </item>       <item>         <key>Copyright</key>         <value/>       </item>       <item>         <key>Issues</key>         <value/>       </item>       <item>         <key>Owner</key>         <value/>       </item>       <item>         <key>Sign off</key>         <value/>       </item>       <item>         <key>Speciality</key>         <value/>       </item>       <item>         <key>User roles</key>         <value/>       </item>     </other_details>   </description>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">     <items>       <item>         <key>Technical.ﻩ Technical Traceability</key>         <value>{~AHSID~9fe06ad4-4741-4f36-bb0c-36deafe261b7~NAME~Palliative Acute Care Admission Medication Order Panel.oet}</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antifungals&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;nystatin Oint 100 000 unit/g&apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;apply to affected *** area *** times per day&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;Opioid analgesics are commonly used to treat pain related to progressive and advanced disease. Due to wide variations in pharmacokinetics, bioavailability, metabolism and response in patients, opioid doses cannot be estimated or calculated in advance (NICE, 2016), and therefore are not included in this order set. Opioid selection and dose titration must be individualized to account for the patient’s disease burden, prognosis, pain severity, previous use of opioids, history of substance use disorder, presence of hepatic or renal impairment, and other individual variables. If clinically appropriate, opioid analgesics can be ordered as individual items, separate from the order set.&lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ibuprofen Tablet; 200 mg PO every 8 hours&apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Maximum 1200 mg per day&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Analgesic and Antipyretics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ibuprofen Tablet; 200 mg PO every 4 hours PRN for pain.&apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Maximum 1200 mg per day&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;PO administration or slow infusion via IV are preferred for metoclopramide to reduce the risk of extrapyramidal syndromes such as akathisia.&amp;nbsp; Suggest 5mg for mild to moderate nausea or if CrCl less than 40 mL/min; 10 mg for moderate to severe nausea, and CrCl over 40 mL/min&lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ondansetron Oral Disintegrating tablet; 4 mg PO every 8 hours&apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Restricted to use with patients who have difficulty swallowing tablets or capsules OR patients actively vomiting without established IV access&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Antiemetics&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;ondansetron Oral Disintegrating tablet; 4 mg PO every 8 hours PRN for nausea and/or vomiting&apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Restricted to use with patients who have difficulty swallowing tablets or capsules OR patients actively vomiting without established IV access&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laxatives&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>Transform.Technical Notes</key>         <value>&lt;p&gt;Hyperlink &quot;AHS Pharmacy Services table&quot; with the hyperlink:&amp;nbsp;https://insite.albertahealthservices.ca/Main/assets/tms/phm/tms-phm-pub-dtb-oic-supplement.pdf&lt;/p&gt;</value>       </item>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;For dosing of laxatives for treatment of opioid-induced constipation refer to AHS Pharmacy Services table. &lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Sedatives and Hypnotics&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;&lt;em&gt;Sleep Promotion:&amp;nbsp; Implement non-pharmacological sleep promotion measures (warm milk; warm blankets; hand rub; low light/minimize noise; calm approach; avoid caffeinated beverages).&amp;nbsp; If pharmacologic assistance is required low dose is advised.&lt;/em&gt;&lt;/p&gt;</value>       </item>     </items>   </annotations>   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Other&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;midazolam injection; 5 mg IV/SUBCUTANEOUSLY every 1 hour PRN for refractory active seizure greater than 2 min and/or massive distressing hemorrhage. &apos;]/activities[at0001]">     <items>       <item>         <key>CKT.Clinical Guidance</key>         <value>&lt;p&gt;Notify MRHP if midazolam is ineffective&lt;/p&gt;</value>       </item>     </items>   </annotations>   <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Palliative Acute Care Admission Medication Order Panel">     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Antifungals">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b042c515-ee2c-4ede-a97c-d0f32ac2f018" concept_name="PHARM nystatin ORAL liquid 100 000 unit/mL Order" max="1" path="/items" name="nystatin Oral liquid 100 000 unit/mL; 500,000 units SWISH and SWALLOW QID for 7 days then reassess"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f6907326-3f96-46f6-bc91-55dc4162873b" concept_name="PHARM nystatin Oint 100 000 unit/g Order" max="1" path="/items" name="nystatin Oint 100 000 unit/g"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Analgesic and Antipyretics">       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen Tablet Order" max="1" path="/items" name="acetaminophen Tablet; 325 mg PO every 6 hour"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen Tablet Order" max="1" path="/items" name="acetaminophen Tablet; 325 mg PO every 6 hours PRN for pain and mild fever"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen Tablet Order" max="1" path="/items" name="ibuprofen Tablet; 200 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b65d69fd-b397-4934-9e04-fa563817b625" concept_name="PHARM ibuprofen Tablet Order" max="1" path="/items" name="ibuprofen Tablet; 200 mg PO every 4 hours PRN for pain."/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Antiemetics">       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide Tablet Order" max="1" path="/items" name="metoclopramide Tablet; 10 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="05b202cc-0015-412c-9c83-ed0c7727d1f0" concept_name="PHARM metoclopramide Tablet Order" max="1" path="/items" name="metoclopramide Tablet; 10 mg PO every 8 hours PRN for nausea and/or vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM metoclopramide injection Order" max="1" path="/items" name="metoclopramide injection; 10 mg IV/SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a9b485b3-6681-44f9-b0fb-1949efbd6d85" concept_name="PHARM metoclopramide injection Order" max="1" path="/items" name="metoclopramide injection; 10 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron Tablet Order" max="1" path="/items" name="ondansetron Tablet; 4 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ceb70162-69de-42da-b231-05ff8dbc8eae" concept_name="PHARM ondansetron Tablet Order" max="1" path="/items" name="ondansetron Tablet; 4 mg PO every 8 hours PRN for nausea and/or vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron Oral Disintegrating tablet Order" max="1" path="/items" name="ondansetron Oral disintegrating tablet; 4 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a7014313-c3f3-4fc4-9077-6d796f649b99" concept_name="PHARM ondansetron Oral Disintegrating tablet Order" max="1" path="/items" name="ondansetron Oral disintegrating tablet; 4 mg PO every 8 hours PRN for nausea and/or vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ondansetron injection Order" max="1" path="/items" name="ondansetron injection; 4 mg IV/SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="80b79825-a35f-40f3-ba6f-030ce06fa116" concept_name="PHARM ondansetron injection Order" max="1" path="/items" name="ondansetron injection; 4 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Gastrointestinal Agents">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ce6336c2-0c67-492a-98f2-5f64630d4245" concept_name="PHARM octreotide injection Order" max="1" path="/items" name="octreotide injection; 100 mcg SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f5df0026-4c75-406d-bb2e-4773e1c528b2" concept_name="PHARM pantoprazole magnesium ENTERIC-COATED tablet Order" max="1" path="/items" name="pantoprazole magnesium Enteric-coated tablet; 40 mg PO every 12 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c8e60c0b-e28c-475c-83c5-2d3e7186edb0" concept_name="PHARM raNITIdine Tablet Order" max="1" path="/items" name="raNITIdine Tablet; 150 mg PO every 12 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="94b2133a-6878-413e-b41b-a3c78f004874" concept_name="PHARM raNITIdine injection Order" max="1" path="/items" name="raNITIdine injection; 50 mg IV/SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4289ae0a-6696-42a0-a472-5dac79de66b0" concept_name="PHARM hyoscine butylbromide injection Order" max="1" path="/items" name="hyoscine butylbromide injection; 10 mg SUBCUTANEOUSLY every 8 hours"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laxatives">       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1071327b-42fc-4918-80d7-5580f593434a" concept_name="PHARM bisaCODyl Tablet Order" max="1" path="/items" name="bisaCODyl Tablet; 10 mg PO every 24 hours PRN for constipation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="b7a7e48f-eb4a-47e2-82f9-c191ebd189f1" concept_name="PHARM bisaCODyl (DULCOLAX) Suppository 10 mg Order" max="1" path="/items" name="bisaCODyl (Dulcolax) Suppository 10 mg; PR every 24 hours PRN for constipation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c67adad-7403-4f0b-881e-1a44ddac56a1" concept_name="PHARM lactulose ORAL liquid 667 mg/mL Order" max="1" path="/items" name="lactulose Oral liquid 667 mg/mL; 15 mL PO every 12 hours for constipation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4c67adad-7403-4f0b-881e-1a44ddac56a1" concept_name="PHARM lactulose ORAL liquid 667 mg/mL Order" max="1" path="/items" name="lactulose Oral liquid 667 mg/mL; 15 mL PO every 24 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1d48b2f1-3f85-465b-8e2f-00039a0b31b6" concept_name="PHARM polyethylene glycol 3350 Powder Order" max="1" path="/items" name="polyethylene glycol 3350 Powder; 17 grams PO every 24 hours PRN for constipation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e3097b98-bb4b-4ff0-8d67-c0d87fa81362" concept_name="PHARM sennosides Tablet Order" max="1" path="/items" name="sennosides Tablet; 17.2 mg PO every 12 hours PRN for constipation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e3097b98-bb4b-4ff0-8d67-c0d87fa81362" concept_name="PHARM sennosides Tablet Order" max="1" path="/items" name="sennosides Tablet; 17.2 mg PO every bedtime"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Central Nervous System Agents">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35f4467d-377f-4566-9ac3-01a0af1537d1" concept_name="PHARM haloperidol Tablet Order" max="1" path="/items" name="haloperidol Tablet; 1 mg PO every 8 hours PRN for nausea and/or vomiting and/or agitation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35f4467d-377f-4566-9ac3-01a0af1537d1" concept_name="PHARM haloperidol Tablet Order" max="1" path="/items" name="haloperidol Tablet; 1 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d22d5b2-02b0-42ed-9870-188ce381b761" concept_name="PHARM haloperidol injection Order" max="1" path="/items" name="haloperidol injection; 1 mg IV/SUBCUTANEOUSLY every 8 hours PRN for nausea and/or vomiting and/or agitation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2d22d5b2-02b0-42ed-9870-188ce381b761" concept_name="PHARM haloperidol injection Order" max="1" path="/items" name="haloperidol injection; 1 mg IV/SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5fef6796-9e19-4737-8891-4980937e6343" concept_name="PHARM methotrimeprazine Tablet Order" max="1" path="/items" name="methotrimeprazine Tablet; 12.5 mg PO every 8 hours PRN for nausea and/or vomiting and/or agitation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5fef6796-9e19-4737-8891-4980937e6343" concept_name="PHARM methotrimeprazine Tablet Order" max="1" path="/items" name="methotrimeprazine Tablet; 12.5 mg PO every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1941460d-469a-4cd1-b597-9e7ba8cb3711" concept_name="PHARM methotrimeprazine injection Order" max="1" path="/items" name="methotrimeprazine injection; 12.5 mg IV/SUBCUTANEOUSLY every 8 hours PRN for agitation"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1941460d-469a-4cd1-b597-9e7ba8cb3711" concept_name="PHARM methotrimeprazine injection Order" max="1" path="/items" name="methotrimeprazine injection; 12. 5 mg IV/SUBCUTANEOUSLY every 8 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="18aa04db-e8be-486b-8e36-efaee72ff067" concept_name="PHARM OLANZapine Tablet Order" max="1" path="/items" name="OLANZapine Tablet; 2.5 mg PO every 12 hours PRN for anxiety and/or agitation and/or nausea/vomiting"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="18aa04db-e8be-486b-8e36-efaee72ff067" concept_name="PHARM OLANZapine Tablet Order" max="1" path="/items" name="OLANZapine Tablet; 5 mg PO at bedtime"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c640cdd5-18b1-419e-a352-4c37c29fc4b0" concept_name="PHARM OLANZapine Oral Disintegrating tablet Order" max="1" path="/items" name="OLANZapine Oral disintegrating tablet; 5 mg PO every 24 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c640cdd5-18b1-419e-a352-4c37c29fc4b0" concept_name="PHARM OLANZapine Oral Disintegrating tablet Order" max="1" path="/items" name="OLANZapine Oral disintegrating tablet; 2.5 mg PO every 12 hours PRN for anxiety and/or agitation and/or nausea/vomiting"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Sedatives and Hypnotics">       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="9605575f-0743-46c5-b7f1-70302015c570" concept_name="PHARM zopiclone Tablet Order" max="1" path="/items" name="zopiclone Tablet; 3.75 mg PO every HS"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fdf81754-7b74-4233-9e72-ea993b94e65f" concept_name="PHARM mirtazapine Tablet Order" max="1" path="/items" name="mirtazapine Tablet; 7.5 mg PO every HS"/>     </Item>     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Other">       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="aa4c20bb-5d80-4726-9ce7-2a979e32d4f2" concept_name="PHARM dexamethasone Tablet Order" max="1" path="/items" name="dexAMETHasone Tablet; 6 mg PO every 24 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d0c9c00c-2757-42de-be79-7e4716a04e95" concept_name="PHARM dexamethasone injection Order" max="1" path="/items" name="dexAMETHasone injection; 6 mg IV/SUBCUTANEOUSLY every 24 hours"/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e8443d3-a1d0-42b3-b9b2-b80bf7d202de" concept_name="PHARM midazolam injection Order" max="1" path="/items" name="midazolam injection; 5 mg IV/SUBCUTANEOUSLY every 1 hour PRN for refractory active seizure greater than 2 min and/or massive distressing hemorrhage. "/>       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e8443d3-a1d0-42b3-b9b2-b80bf7d202de" concept_name="PHARM midazolam injection Order" max="1" path="/items" name="midazolam injection; 2 mg IV/SUBCUTANEOUSLY every 1 hour PRN for ***"/>     </Item>   </definition>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>   </integrity_checks>   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>   </integrity_checks> </template>